It is therefore not surprising that the XBP1 branch of the UPR pathway has been implicated in many protein aggregation diseases including Alzheimers [16, 17], Huntington’s disease [18, 19], type II diabetes [20] and several skeletal conditions [5, 7, 12, 21] amongst others. This evidence concerns the gene XBP1 and juvenile Huntington disease.